Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis | Zendy

Shin Ito | Zendy; Mitsuru Yasuda | Zendy; Kyoko Hatazaki | Zendy; Kosuke Mizutani | Zendy; Tomohiro Tsuchiya | Zendy; Shigeaki Yokoi | Zendy; Masahiro Nakano | Zendy; Takashi Deguchi | Zendy

Open Access

Microbiological efficacy and tolerability of a single-dose regimen of 1 g of ceftriaxone in men with gonococcal urethritis

Author(s) -

Shin Ito,

Mitsuru Yasuda,

Kyoko Hatazaki,

Kosuke Mizutani,

Tomohiro Tsuchiya,

Shigeaki Yokoi,

Masahiro Nakano,

Takashi Deguchi

Publication year - 2016

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkw180

Subject(s) - ceftriaxone , tolerability , regimen , medicine , neisseria gonorrhoeae , urethritis , antibiotics , adverse effect , gastroenterology , surgery , microbiology and biotechnology , biology

We treated men with gonococcal urethritis with a single-dose regimen of 1 g of ceftriaxone, which is recommended as the first-line treatment for gonorrhoea in Japan, to determine its microbiological outcomes and tolerability.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research